HC Wainwright & Co. Reiterates Buy on Calumet, Maintains $25 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Amit Dayal has reiterated a Buy rating on Calumet (NASDAQ:CLMT) and maintained a $25 price target.
August 12, 2024 | 6:56 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. analyst Amit Dayal has reiterated a Buy rating on Calumet and maintained a $25 price target.
The reiteration of a Buy rating and maintenance of a $25 price target by a reputable analyst can positively influence investor sentiment and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100